In this report, we cover catalysts from 23 drugs, devices and diagnostics expected to occur in early 2019. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided. The results of the drug catalysts highlighted in our Biomedtracker Q4 2018 Outlook Report can be found on Page 4. At the end of this report, we have included a list of Large Impact catalysts through Early 2019.

For the full report, please download the PDF version at the top of this page. Additionally, the catalyst list is provided in Excel by downloading the supplemental material at the top of this page.

For more information on Meddevicetracker, visit its website www.meddevicetracker.com.

Like our report? Have any questions or feedback? Please let us know at askanalyst@sagientresearch.com.

For our disclosures, please read the Biomedtracker Research Standards.